264 related articles for article (PubMed ID: 2901906)
1. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
2. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
3. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic mice.
Kuo MT; Zhao JY; Teeter LD; Ikeguchi M; Chisari FV
Cell Growth Differ; 1992 Aug; 3(8):531-40. PubMed ID: 1356418
[TBL] [Abstract][Full Text] [Related]
4. Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines.
Fracasso PM; Slapak CA; Nair S; Modrak D; Draper MP; LeCerf JM; Levy SB
Oncol Res; 1997; 9(4):183-91. PubMed ID: 9268989
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of the mouse multidrug resistance gene family.
Dhir R; Buschman E; Gros P
Bull Cancer; 1990; 77(11):1125-9. PubMed ID: 1980424
[TBL] [Abstract][Full Text] [Related]
8. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
9. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms.
Slovak ML; Coccia M; Meltzer PS; Trent JM
Anticancer Res; 1991; 11(1):423-8. PubMed ID: 1673331
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines.
Bradley G; Naik M; Ling V
Cancer Res; 1989 May; 49(10):2790-6. PubMed ID: 2565764
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of multidrug resistance in tumor cells.
Roninson IB
Clin Physiol Biochem; 1987; 5(3-4):140-51. PubMed ID: 2887329
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
[TBL] [Abstract][Full Text] [Related]
14. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines.
Nieuwint AW; Baas F; Wiegant J; Joenje H
Cancer Res; 1992 Aug; 52(16):4361-71. PubMed ID: 1353703
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-fos in human and murine multidrug-resistant cells.
Bhushan A; Abramson R; Chiu JF; Tritton TR
Mol Pharmacol; 1992 Jul; 42(1):69-74. PubMed ID: 1353251
[TBL] [Abstract][Full Text] [Related]
17. Expression of the P-glycoprotein gene in multidrug-resistant Chinese hamster ovary cells.
Mukhopadhyay T; Kuo MT
Anticancer Res; 1989; 9(3):575-8. PubMed ID: 2569855
[TBL] [Abstract][Full Text] [Related]
18. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).
Weber JM; Sircar S; Horvath J; Dion P
Cancer Res; 1989 Nov; 49(21):5779-83. PubMed ID: 2571411
[TBL] [Abstract][Full Text] [Related]
19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
